Urokinase-type plasminogen activator blockade ameliorates experimental colitis in mice

Area of Science:

• Gastroenterology
• Immunology
• Molecular Biology

Background:

• Angiogenesis-related factors are implicated in ulcerative colitis (UC) pathogenesis.
• The specific mechanisms of these factors in UC remain unclear.

Purpose of the Study:

• To investigate the role of angiogenesis-related factors, particularly urokinase-type plasminogen activator (uPA), in UC.
• To evaluate the therapeutic potential of targeting uPA in colitis models.

Main Methods:

• Antibody array and real-time PCR to assess angiogenesis factor expression in UC tissues.
• Immunohistochemistry to localize uPA expression.
• Murine colitis model induced by dextran sulfate sodium (DSS) using uPA knockout mice and a uPA-selective inhibitor (UK122).
• Cytokine/chemokine assays to analyze inflammatory markers.

Main Results:

• uPA was highly expressed in neutrophils of inflamed UC colorectal tissue and correlated with disease severity.
• uPA knockout mice and mice treated with a uPA inhibitor showed significantly reduced colitis severity and histological damage.
• Treatment with uPA inhibition led to downregulation of RANTES.

Conclusions:

• uPA plays a significant role in the pathogenesis of ulcerative colitis.
• uPA blockade is a promising therapeutic strategy for managing colitis.
• RANTES may be involved in the inflammatory pathway regulated by uPA in colitis.